Add BrightSurf on Google Email

Professor Sadaf Farooqi announced as winner of the new Joint ‘Endocrinology Across the Life Course Award’ at the Joint Congress of ESPE and ESE 2025

Professor Sadaf Farooqi has been awarded the inaugural Joint ‘Endocrinology Across the Life Course Award’ for her groundbreaking research on human eating behaviour and severe childhood obesity. Her work has changed attitudes towards people with severe obesity by demonstrating its biological basis.

Providing medications for opioid use disorder to people with HIV recently released from incarceration in South Africa

A pilot program was conducted in South Africa to provide harm reduction and medications for opioid use disorder among people living with HIV and illicit opioid use. The study found low uptake of medication-assisted treatment after release, citing perceived ineffectiveness and delays in initiation.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalJournal of Correctional Health Care·TypeObservational study·DateMay 6, 2025

New radiotherapy technique aims to protect the heart during lung cancer treatment

A new study introduces the RAPID-RT study, which uses a rapid-learning approach to evaluate the impact of treatment modifications in radiotherapy. The technique aims to reduce cardiac toxicity and improve survival in lung cancer patients by minimising dose to the top of the heart, a previously identified risk area.

SourceEuropean Society for Radiotherapy and Oncology (ESTRO)·JournalRadiotherapy and Oncology·TypeRandomized controlled/clinical trial·DateMay 4, 2025

Chinese Neurosurgical Journal study explores new treatment strategy for patients with glioblastoma

Researchers investigated the clinical outcomes of concurrent TTFields therapy with CRT in patients with newly diagnosed glioblastoma, finding no significant difference in survival outcomes compared to adjuvant therapy. The study also showed comparable safety profiles for both treatment groups.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeExperimental study·DateMay 1, 2025

Substance use accelerates brain aging through distinct molecular pathways, groundbreaking study reveals

Researchers identified unique biological mechanisms that cause premature aging in the brains of individuals with alcohol, opioid, and stimulant use disorders. Different substances appear to hijack the brain's natural aging rhythm through distinct molecular mechanisms, though some pathways are shared across different substance types.

SourceGenomic Press·JournalGenomic Psychiatry·TypeExperimental study·DateApr 29, 2025

Non-risk-based lung cancer screening with low-dose computed tomography

A non-risk-based lung cancer screening approach using low-dose computed tomography (LDCT) in Chinese populations detects a significant number of early-stage lung cancers. The study found that incorporating non-high-risk individuals into screening programs can lead to a greater detection rate and improved patient outcomes.

SourceNational Center for Respiratory Medicine·JournalJAMA·TypeRandomized controlled/clinical trial·DateApr 29, 2025

Bridging the AI gap in medicine: new framework targets family doctor education

A new curriculum framework helps train future family physicians to integrate AI into their practice, addressing a critical gap in medical training. The AIFM-ed framework provides a structured road map for medical educators to bridge the AI gap, ensuring that future doctors are clinically competent and technologically fluent.

SourceJMIR Publications·JournalJMIR Medical Education·TypeSystematic review·DateApr 29, 2025

A new CAR-T therapy from Sant Pau achieves positive results in a high proportion of patients with a refractory type of lymphoma

A new CAR-T therapy, HSP-CAR30, has achieved positive results in a high proportion of patients with refractory CD30+ lymphoma. The treatment promotes the expansion of memory T cells, leading to durable responses and improved clinical outcomes.

SourceInstitut de Recerca Sant Pau (Sant Pau Research Institute)·JournalBlood·TypeRandomized controlled/clinical trial·DateApr 29, 2025

University of Houston BRAIN, TIRR Memorial Hermann develop first wearable pediatric soft exoskeleton made of smart materials

The MyoStep project represents a significant advancement in pediatric mobility aids for children with cerebral palsy, addressing motor impairments that restrict participation in physical activities. The soft power suit provides a lightweight, discreet solution tailored to fit seamlessly into the lives of children and their families.

SourceUniversity of Houston·JournalIEEE Electron Devices Magazine·DateApr 29, 2025

Spiritual health practitioners reveal key motivations in psychedelic-assisted therapy practice

A study by Emory University researchers has found that spiritual health practitioners' personal experiences with psychedelics drive their careers in the emerging field of psychedelic-assisted therapy. The study introduced a novel training approach, emphasizing self-literacy and reflective learning to balance personal experience with cl...

SourceGenomic Press·JournalPsychedelics·TypeExperimental study·DateApr 29, 2025

Ulrich Steidl, M.D., Ph.D., at Albert Einstein College of Medicine Elected to Association of American Physicians

Dr. Ulrich Steidl, a leading expert in blood diseases, has been elected to the Association of American Physicians for his groundbreaking research on myelodysplastic syndromes and acute myeloid leukemia. His work seeks to understand the characteristics of pre-leukemic stem cells and develop drugs to interrupt their progression.

BNT162b2 vaccine not only targets COVID-19 virus, but may also help reduce and control innate inflammation

The BNT162b2 vaccine not only targets the COVID-19 virus but also helps reduce and control innate inflammation to other bacterial and fungal pathogens. By reprogramming innate immune cells, the vaccine reduces pro-inflammatory mediators, providing potential benefits beyond its primary target.

SourceTrinity College Dublin·JournalClinical Immunology·TypeExperimental study·DateApr 28, 2025

AACR 2025: Colon cancer risk reduction, predicting melanoma spread and new drug therapies among Ohio State findings

Researchers at Ohio State University have identified new targeted therapies for treating small cell lung cancer, predicting melanoma spread, and reducing endometrial cancer risk. A 31-gene expression profile has been developed to identify patients at high risk of melanoma spread, allowing for closer monitoring and earlier treatment.

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Dr. Robert C. Bast, Jr., a pioneer in cancer science, receives the AACR-Daniel D. Von Hoff Award for his decades-long dedication to nurturing the next generation of cancer research leaders. His groundbreaking discoveries have saved countless lives and transformed ovarian cancer detection and management.

New way to prevent duodenal cancer

Bonn researchers found higher numbers of type 3 innate lymphoid cells in duodenum tissue of FAP patients, producing interleukin-17A which stimulates ROS production and DNA damage. This suggests a local environment favoring cancer development, prompting a new approach to preventing duodenal cancer.

SourceUniversitatsklinikum Bonn·JournalNature Communications·DateApr 25, 2025

A new way of visualizing blood pressure data can help doctors better manage patients with hypertension

A new study from the University of Missouri highlights how 'smoothed' graphs can help doctors better manage patients with hypertension. The findings suggest that these graphs can reduce errors in assessing blood pressure control, potentially alleviating pressure on the healthcare system.

SourceUniversity of Missouri-Columbia·JournalJournal of General Internal Medicine·TypeExperimental study·DateApr 24, 2025

Society for cardiovascular angiography & interventions scientific sessions 2025 features latest clinical innovations in cardiology care

The Society for Cardiovascular Angiography & Interventions (SCAI) meeting will highlight advances in interventional cardiology, including novel treatments and techniques. The conference features over 500 faculty, 700 posters, and 86 oral abstracts, with a focus on improving patient care and outcomes.